Beta Bionics (BBNX) Equity Average (2024 - 2026)

Beta Bionics has disclosed Equity Average across 3 years of filings, most recently posting $279.4 million for Q1 2026.

• Equity Average for Q1 2026 came in at $279.4 million, up 717.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $279.4 million (up 717.14% YoY), and the FY2025 annual result was $21.1 million, up 109.42% from the prior year.
• Equity Average came in at $279.4 million for Q1 2026 at Beta Bionics, down from $291.2 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $307.7 million in Q2 2025 to a low of -$237.1 million in Q4 2024.
• The 3-year median for Equity Average is $34.2 million (2025), against an average of $35.8 million.
• Across the five-year window, Equity Average jumped 116.38% in 2025 and soared 717.14% in 2026, its largest moves.
• Beta Bionics' Equity Average stood at -$237.1 million in 2024, then soared by 222.81% to $291.2 million in 2025, then decreased by 4.04% to $279.4 million in 2026.
• The last three Equity Average figures came in at $279.4 million (Q1 2026), $291.2 million (Q4 2025), and $298.2 million (Q3 2025), per Business Quant data.